Pfizer
Juliana Chen is an accomplished professional with extensive experience in business operations, innovation, and brand strategy within the pharmaceutical and consumer goods sectors. Currently serving as the Director of Business Operations & Consulting Services at Pfizer since 2019, Juliana also leads the PGS Diversity, Equity & Inclusion partnership and Early Talent Program. Prior roles at Pfizer include Director of Global Innovation Wellness, where strategic plans for energy and immunity were developed, and Chief of Staff to the Division CMO, driving global brand development and marketing strategies. Juliana's earlier experience includes leadership positions at Blue Marlin and Smart Design, focusing on branding and marketing strategies, as well as roles at Kraft Foods and Colgate-Palmolive. Juliana holds an MBA in Marketing from NYU Stern School of Business and has a degree from Harvard University.
This person is not in any teams
Pfizer
605 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.